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Local macrophage proliferation in human glomerulonephritis.
Background. Local macrophage proliferation has been described in
several animal models of glomerulonephritis (GN), but its significance in
human disease is unknown.
Methods. Double immunostaining for CD68 and the proliferating cell
nuclear antigen (PCNA) was used to identify macrophage proliferation in
84 biopsies from a variety of glomerulonephridities.
Results. A small resident population of glomerular and interstitial
CD681 macrophages was identified in normal human kidney, of which
only 1 to 2% showed evidence of proliferation on the basis of PCNA
expression. A mild macrophage infiltrate, with only occasional proliferat-
ing macrophages, was seen in the less aggressive forms of GN (minimal
change disease, non-IgA mesangioproliferative GN and IgA nephropa-
thy). This was in sharp contrast to the more aggressive forms of disease
(lupus class IV, vasculitis-associated GN, crescentic GN and mesangio-
capillary proliferative GN), in which the prominent macrophage infiltrates
contained many proliferating macrophages, accounting for 28 to 47% of
the total macrophage population. Macrophage proliferation was largely
restricted to areas of severe tissue damage (glomerular segmental prolif-
erative lesions, crescents and foci of tubulointerstitial damage), suggesting
that local proliferation is a mechanism for amplifying macrophage-
mediated injury. Glomerular and interstitial macrophage proliferation
gave a significant correlation with loss of renal function (P , 0.0001) and
histologic lesions (P , 0.0001), but not with proteinuria. Interstitial T-cell
proliferation also gave a significant correlation with loss of renal function
and histologic damage, even though proliferation within the T-cell popu-
lation was much lower than in the macrophage population.
Conclusions. This study demonstrates that macrophage proliferation is
a feature of the more aggressive forms of human GN. Local proliferation
may be an important mechanism for amplifying macrophage-mediated
renal injury. In addition, the degree of local macrophage proliferation may
be a useful diagnostic and prognostic indicator for human GN.
Glomerular and interstitial macrophage accumulation is
a feature of almost all forms of human glomerulonephritis
(GN), and the intensity of the macrophage infiltrate corre-
lates with loss of renal function and histologic damage at
the time of biopsy and is a predictor of renal outcome
[1–4]. Direct evidence that macrophages cause renal injury
has come from animal studies in which a variety of anti-
macrophage strategies have been shown to inhibit the
induction or progression of renal injury in experimental
GN [5–10].
There has been much interest in the mechanisms by
which macrophages accumulate within the kidney during
disease. The entry of blood monocytes into the injured
kidney is regulated by a variety of chemokines and adhesion
molecules [11–13]. An additional mechanism contributing
to macrophage accumulation and renal injury in experi-
ment disease is local proliferation [14]. High levels of local
macrophage proliferation, identified by the presence of
mitotic figures, incorporation of bromodeoxyuridine and
expression of the proliferating cell nuclear antigen
(PCNA), have been demonstrated in models of severe
renal injury [15, 16]. The degree of local macrophage
proliferation correlates with the severity of renal injury,
being prominent in rat crescentic anti-glomerular basement
membrane (GBM) GN and acute allograft rejection, but
only occasionally seen in models featuring mild renal injury
[15–20]. Local proliferation is largely restricted to areas of
severe tissue damage, such as glomerular segmental prolif-
erative lesions, crescents and granulomatous lesions [21].
Thus, local proliferation has been postulated as a mecha-
nism for amplifying macrophage-mediated tissue injury.
While there is good evidence to support the presence of
local macrophage proliferation in experimental disease
models, the significance of these observations to human
GN remain to be established. The aim of this study was,
therefore, to seek evidence of macrophage proliferation in
a range of human glomerulonephridities.
METHODS
Patients
A total of 83 biopsies from the Department of Nephrol-
ogy, Monash Medical Centre and the Department of
Nephrology, First Affiliated Hospital of Sun Yat-Sen Uni-
versity of Medical Sciences were examined (48 males and
35 females; average age 42 years, range 13 to 82). Disease
categories were as follows: minimal change disease (MCD,
N 5 9), non-IgA mesangial proliferative GN (non-IgA
MPGN, N 5 12), IgA nephropathy (IgAN, N 5 19),
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membranous GN (memb GN, N 5 4), focal glomerular
sclerosis (FGS, N 5 10), lupus nephritis WHO Class II
(lupus II, N 5 5), lupus WHO class IV (lupus IV, N 5 5),
crescentic GN (cres GN, N 5 9; defined as .50% cres-
cents, excluding IgAN and lupus), nephritis-associated with
vasculitis (vasc GN, N 5 5; with ,50% crescents), mesan-
giocapillary proliferative GN (MCPGN, N 5 5). All pa-
tients were diagnosed on the basis of biopsy examination.
Measurements of 24-hour protein excretion, serum creati-
nine, and creatinine clearance were taken for each patient
at the time of biopsy. Morphologically normal human
kidney was obtained from the unaffected areas of five renal
tumor nephrectomy specimens and used as control tissue in
this study.
Histopathology
Formalin-fixed, paraffin-embedded biopsy tissue sections
(4 mm) were stained with hematoxylin and eosin. The
percentage of glomeruli exhibiting segmental proliferative
lesions or crescents was scored in 10 to 30 glomerular
cross-sections (gcs) per biopsy. Glomerular hypercellularity
was assessed as follows: 0 5 normal (less than 60 cells/gcs);
1 5 mild (60 to 90 cells/gcs); 2 5 moderate (90 to 120
cells/gcs); 3 5 severe (more than 120 cells/gcs). The percent
of the tubulointerstitial area exhibiting tubulitis, tubular
dilation, atrophy, or fibrosis was assessed on H&E stained
sections. All scoring was performed on blinded sections.
Antibodies
Monoclonal antibodies (mAb) purchased from Dako
(Glostrup, Denmark) were: KP1, mouse anti-CD68 present
in lysosomes of monocytes and macrophages [22]; UCHL1,
mouse anti-CD45RO recognizing mature, activated T-cells
and a subset of resting T-cells [23]; PC10, mouse anti-
proliferating cell nuclear antigen (PCNA), which recog-
nizes cells in the G1, S, and G2 phases of the cell cycle [24,
25]; MIB-1, mouse anti-Ki-67 antigen, which recognizes
cells in the G1, S, G2 and M phases of the cell cycle
(Immunotech, Marseille, France) [26]. Peroxidase- and
alkaline phosphatase-conjugated goat anti-mouse IgG,
mouse peroxidase anti-peroxidase complexes (PAP), and
mouse alkaline phosphatase anti-alkaline phosphatase
complexes (APAAP) were purchased from Dako.
Immunohistochemistry
Two-color immunohistochemistry staining used a micro-
wave-based technique [27]. Briefly, paraffin sections (4 mm)
of formalin-fixed tissues were dewaxed, treated with 10
minutes of microwave oven heating in 0.01 M sodium citrate
buffer (pH 6.0) at 2450 MHz and 800 watts power. This
treatment was used to retrieve the cytoplasmic antigen
recognized by the KP1 mAb, but was not used in detection
of the UCHL1 antigen. Slides were then washed twice in
PBS, preincubated with 10% fetal calf serum (FCS) and
10% normal goat serum in PBS for 20 minutes, drained and
incubated with KP1 (1:1000) or UCHL1 (1:200) mAb at
4°C overnight. After washing in PBS, endogenous peroxi-
dase was inactivated by incubation in 0.3% H2O2 in meth-
anol, and sections were then incubated with peroxidase-
conjugated goat anti-mouse IgG followed by mouse PAP
Fig. 1. Renal function data of the patient population. Measurements of (A)
serum creatinine, (B) creatinine clearance, and (C) urinary protein excretion,
are shown for the different disease types. Data are shown as mean 6 SEM.
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complexes and developed with 3,3-diaminobenzidine to
produce a brown color. At this point, slides were treated by
another round of microwave heating in order to denature
IgG molecules bound to the tissue and thus prevent an
antibody cross reaction and to improve antibody access to
nuclei. Following a second preincubation step as above,
sections were labeled with the PC10 mAb (1:1000) at 4°C
overnight. After washing in PBS, sections were labeled
Fig. 2. Immunohistochemistry detection of proliferating cells in a case of crescentic glomerulonephritis. (A) Detection of proliferating cells (dark
nuclei) within the glomerular tuft and many proliferating cells within the crescent using the PC-10 (anti-PCNA) mAb. (B) A very similar result showing
proliferating cells (dark nuclei) within the glomerular tuft and many proliferating cells within the crescent is seen using the MIB-1 (anti-Ki-67) mAb.
Sections were counterstained with PAS. Magnification 3200.
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sequentially with alkaline phosphatase-conjugated goat an-
ti-mouse IgG and mouse APAAP complexes and devel-
oped with Fast Blue BB Base (Sigma Chemical Co., St.
Louis, MO, USA) to produce a blue color. Sections were
counterstained with periodic acid-Schiff reagent without
hematoxylin.
For detection of the Ki-67 antigen, sections were micro-
wave oven heated, digested with 0.1% trypsin for 20
minutes at 37°C in 0.1 M sodium acetate pH 4.0, washed in
PBS, incubated with the MIB-1 (1:100) mAb overnight
followed by with peroxidase-conjugated goat anti-mouse
IgG followed by mouse PAP complexes and developed with
3,3-diaminobenzidine.
Quantitation of immunohistochemical staining
Antibody stained cells in tissue sections were quantitated
as previously described [21]. Briefly, the number of single
and double stained cells were counted in 10 to 30 gcs per
biopsy. The number of single and double stained cells in the
cortical interstitium were counted in at least 20 consecutive
high power fields by means of a 0.02 mm2 graticule fitted in
the eyepiece of microscope, avoiding only glomeruli and
large vessels. All scoring was performed on blinded slides
and the data are presented as the mean 6 SEM per gcs or
mm2.
Statistical analysis
The number of macrophages, T cells and subsets of
proliferating cells in disease groups were compared to the
normal group using the Mann-Whitney U-test. In addition,
the number of macrophages, T cells and subsets of prolif-
erating cells were compared with measurements of renal
function by the Pearson single correlation coefficient and
with measurements of histologic damage by the Spearman’s
rank coefficient.
RESULTS
Renal function in patient population
Measurements of serum creatinine, creatinine clearance
and urinary protein excretion are shown in Figure 1.
Patients with less aggressive forms of GN (MCD, Non-IgA
MPGN, IgAN and memb GN) had, on average, a normal
rate of creatinine clearance (mean 105, range 64 to 184). In
contrast, those patients with more aggressive forms of GN
(lupus IV, vasc GN, cres GN and MCPGN) had a signifi-
cant reduction in creatinine clearance (mean 33, range 2 to
98). Proteinuria was variable between the diseases, being
heaviest in the memb GN group.
Macrophage proliferation in human glomerulonephritis
Proliferating cells in renal biopsies were detected by
immunostaining for PCNA and Ki-67 antigens, both of
which are expressed in the G1, S, G2 and M phases of the
cell cycle [24–26]. Immunostaining of PCNA required 10
minutes of microwave oven heating to optimize antigen
retrieval. In contrast, immunostaining of the Ki-67 antigen
was more complex, requiring microwave treatment follow-
ing by trypsin digestion to achieve optimal detection of the
antigen. Both antibodies stained a similar number of cells
that had a very similar distribution pattern, as illustrated in
Figure 2. However, staining with the MIB-1 mAb (anti-Ki-
67) was variable between staining runs, presumably due to
a variation in the protease digestion step. Therefore, we
used detection of PCNA as the marker of cell proliferation
in this study.
Double immunostaining of normal human kidney and
the less aggressive forms of human GN (MCD, non-IgA
MPGN, IgAN, memb GN) showed the presence of small
numbers of macrophages within glomeruli, but only occa-
sional proliferating macrophages (Fig. 3A and 4A). In-
creasing numbers of glomerular macrophages were seen in
FGS through to MCPGN, with marked glomerular macro-
phage proliferation evident in aggressive forms of GN
(lupus IV, vasc GN, cres GN and MCPGN). Indeed,
proliferating macrophages accounted for between 29 and
47% of total glomerular macrophages in aggressive forms
of GN (Fig. 4A). Interstitial macrophage accumulation was
evident in most types of GN examined, being most marked
in the more aggressive diseases (Fig. 4B). Few interstitial
proliferating macrophages were seen in the less aggressive
forms of GN; however, interstitial macrophage prolifera-
tion was prominent in aggressive forms of disease in which
they accounted for 28 to 44% of the total macrophage
population (Fig. 4B).
Local macrophage proliferation was largely restricted to
Fig. 3. Double immunohistochemistry staining of macrophage proliferation in human glomerulonephritis. Paraffin sections were stained for KP11
macrophages (brown) in combination with PCNA (blue nuclei) and counterstained with PAS. Examples of non-proliferating macrophages
(KP11PCNA2 cells) are indicated by arrows, and examples of proliferating macrophages (KP11PCNA1 cells) are indicated by arrowheads. (A)
Minimal change disease showing a single glomerular KP11 macrophage and little cell proliferation. (B) Mesangiocapillary proliferative GN showing
prominent glomerular macrophage accumulation, with many of the macrophages proliferating, contributing to severe glomerular hypercellularity. (C)
Lupus nephritis class IV showing substantial local macrophage proliferation within a glomerular segmental proliferative lesion. (D) Crescentic GN
showing macrophage proliferation within the glomerular tuft and in the crescent. (E) Crescentic GN showing high levels of macrophage proliferation
within a focal area of tubulointerstitial damage. (F) Vasculitis-associated GN showing macrophage proliferation and giant cell formation within a
perivascular granulomatous lesion. Note PCNA staining within the giant cell (asterisk). Magnification 3400. The publication of this figure in color was
made possible by a grant from Janssen Cilag Pty Ltd.
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areas of focal tissue damage. Many proliferating macro-
phages were seen in areas of severe glomerular hypercel-
lularity, glomerular segmental proliferative lesions, glomer-
ular crescents, focal tubulointerstitial lesions and in
granulomatous lesions in which multinucleated giant cells
also expressed PCNA (Fig. 3B-F). It should be emphasized
that while high levels of macrophage proliferation were
evident within focal lesions, macrophages comprised only a
minor population of the total number of proliferating cells
(Fig. 3). Most proliferating cells were intrinsic renal cells,
particularly tubular epithelial cells.
There was a substantial variation in the number of
proliferating macrophages in the different biopsies, even
those within the same disease type. As this variation
appeared to reflect the degree of histologic damage, we
examined the relationship between macrophage prolifera-
tion and renal function and histologic injury. As summa-
rized in Table 1, total glomerular macrophages and prolif-
erating glomerular macrophages gave a highly significant
correlation with serum creatinine, creatinine clearance and
glomerular lesions. There was also an excellent correlation
between total interstitial macrophages and proliferating
interstitial macrophages with serum creatinine, creatinine
clearance and tubulointerstitial lesions. However, glomer-
ular and interstitial macrophage populations did not corre-
late with proteinuria.
T-cell proliferation in human glomerulonephritis
Occasional T-cells were seen in the glomerulus and the
interstitium of normal human kidney, but no proliferating
T-cells were detected in either compartment (Fig. 5). Small
numbers of glomerular T-cells were seen in most forms of
human GN. This was highly variable between biopsies such
that increase in glomerular T-cell numbers failed to reach
statistical significance, except in crescentic GN (Fig. 5A).
Occasional proliferating T-cells were observed in diseased
glomeruli, which accounted for between 4 and 17% of the
total T-cell population (Fig. 5A). In contrast, a marked
interstitial T-cell infiltrate was evident in all types of GN
examined. However, despite the high levels of T-cell accu-
mulation within the interstitium, few proliferating T-cells
were seen. Proliferating T-cells accounted for only 1 to 9%
of the total interstitial T-cell population (Fig. 5B). Similar
to proliferating macrophages, the small number of prolif-
erating T-cells present in biopsies were largely restricted to
areas of focal tissue damage.
Statistical analysis found no correlation between glomer-
ular T-cells or proliferating glomerular T-cells and serum
creatinine, creatinine clearance or proteinuria. However,
both populations gave a significant correlation with glomer-
ular lesions (Table 1). Interstitial T-cells and proliferating
interstitial T-cells significantly correlated with serum creat-
inine, creatinine clearance and tubulointerstitial lesions
(Table 1).
DISCUSSION
This study has identified local macrophage proliferation
in human GN. The role of macrophage proliferation in
renal injury and comparisons with studies of experimental
GN are discussed below.
The degree of macrophage proliferation correlated with
the severity of renal injury. This was evident by the small
numbers of proliferating macrophages seen in less aggres-
sive forms of GN compared to that present in aggressive
forms of disease. In addition, macrophage proliferation
gave a highly significant correlation with the loss of renal
function and histologic damage. Similar findings have been
made in animal studies. Few proliferating macrophages are
seen in mild forms of renal injury, such as anti-Thy-1
nephritis, immune complex GN and lipid-induced glomer-
ular injury [17–20]. In contrast, prominent macrophage
proliferation have been demonstrated in aggressive rat
models of allograft rejection and crescentic GN [15, 16].
The high level of macrophage proliferation seen in









Glom seg les Crescents TI lesions
%
Glomerulus cells/gcs
KP11 macrophages 0.60d 20.56d 0.04 0.65d 0.67d 0.60d —
KP11 PCNA1 cells 0.60d 20.52d 20.03 0.62d 0.64d 0.55c —
UCHL11 T-cells 0.11 20.22 20.06 20.07 20.17 20.05 —
UCHL11 PCNA1 cells 0.03 20.13 20.02 20.12 20.13 0.02 —
Interstitium cells/mm2
KP11 macrophages 0.66d 20.64d 0.03 — — — 0.75d
KP11 PCNA1 cells 0.69d 20.58d 20.02 — — — 0.66d
UCHL11 T-cells 0.26 20.41 0.06 — — — 0.70d
UCHL11 PCNA1 cells 0.29a 20.33b 0.02 — — — 0.69d
The number of macrophages (KP11 cells), proliferating macrophages (KP11 PCNA1 cells), T-cells (UCHL11 cells) and proliferating T-cells
(UCHL11 PCNA1 cells) in both the glomerulus and interstitium was compared with parameters of renal function (Pearson correlation coefficient) and
histologic damage (Spearman’s correlation coefficient). Abbreviations are: SCr, serum creatinine; CCr, creatinine clearance; Glom hyp, glomerular
hypercellularity; Glom seg les, glomerular segmental proliferaive lesion; Tub lesions, tubulointerstitial lesions. Data are from 75 patients from all disease
categories. a P , 0.05, b P , 0.01, c P , 0.001, d P , 0.0001
Yang et al: Macrophage proliferation in human GN148
aggressive forms of human GN suggests that local prolifer-
ation is an important mechanism of macrophage accumu-
lation within the injured kidney. However, there must be a
rapid turnover of inflammatory macrophages to prevent the
kidney from simply filling up with these cells. This issue has
been explored in temporal studies of rat crescentic GN.
Local proliferation is a major mechanism of macrophage
accumulation during disease development, while apoptosis
and trafficking to the draining lymph node are the main
routes by which macrophages are rapidly removed from the
kidney [21, 28, 29].
A striking feature of local macrophage proliferation in
human GN is that it is largely restricted to focal areas of
tissue damage. The high level of proliferation is a mecha-
nism of amplifying macrophage numbers within these le-
sions and thus increasing the potential for macrophage-
mediated renal injury. Local macrophage proliferation was
Fig. 4. Quantitation of macrophage accumulation and macrophage pro-
liferation in human glomerulonephritis (GN). The number of KP11
macrophages (M) and KP11PCNA1 proliferating macrophages (f) was
scored in glomeruli (A) and the interstitium (B). Numbers in parentheses
indicate the percentage of KP11 cells expressing PCNA. Data are shown
as mean 6 SEM. *P , 0.05, **P , 0.01, ***P , 0.001 compared to normal
by Mann Whitney U-test.
Fig. 5. Quantitation of T-cell accumulation and T-cell proliferation in
human glomerulonephritis (GN). The number of UCHL11 T-cells (M)
and UCHL1PCNA1 proliferating T-cells (f) was scored in glomeruli (A)
and the interstitium (B). Numbers in parentheses indicate the percentage
of UCHL11 cells expressing PCNA. Note that no UCHL11PCNA1 cells
were observed in glomeruli or the interstitium of normal kidney. Data are
shown as mean 6 SEM. *P , 0.05, **P , 0.01, ***P , 0.001 compared to
normal by Mann Whitney U-test.
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prominent in glomerular segmental proliferative lesions,
crescents, tubulointerstitial lesions and multinucleated gi-
ant cell formation within granulomatous-like lesions in
human GN. Similar observations have been made in rat
crescentic GN [21, 30]. In particular, macrophage prolifer-
ation is thought to precede cell fusion in the formation of
macrophage multinucleated giant cells [31].
What is the mechanism driving local macrophage prolif-
eration in human GN? There is evidence to support a role
for macrophage colony-stimulating factor (M-CSF), a well
characterized macrophage growth factor, in this process.
Studies of murine lupus nephritis and rat crescentic GN
have shown increased glomerular and tubular M-CSF
mRNA and protein expression that correlates with macro-
phage proliferation and accumulation [32–34]. In addition,
a recent study of human GN found an increase in glomer-
ular M-CSF protein expression in cases of IgA nephropathy
and lupus nephritis that correlated with glomerular prolif-
eration and macrophage infiltration [35]. The potential
involvement of other cytokines in local macrophage prolif-
eration, such as macrophage migration inhibitory factor
(MIF), IL-13, granulocyte-macrophage colony-stimulating
factor (GM-CSF) and macrophage stimulating protein,
have yet to be examined in human or experimental glomer-
ulonephritis.
Evidence for T-cell proliferation in human GN was also
shown in this study, although at much lower levels com-
pared to macrophage proliferation. This is consistent with
previous studies demonstrating T-cell activation in human
crescentic GN on the basis of expression of the interleu-
kin-2 receptor [36]. Interstitial proliferating T-cells gave a
highly significant correlation with loss of renal function and
histologic damage, consistent with previous studies [1–4].
In vitro, activated T-cells are a rich source of cytokines and
growth factors, such as MIF, macrophage inflammatory
protein-1b, M-CSF and GM-CSF, which have the potential
to induce blood monocyte accumulation and local macro-
phage proliferation. However, further studies are needed
to determine whether activated T-cells actually synthesize
these molecules within the diseased kidney, and if they
participate in macrophage infiltration and proliferation.
In summary, this study demonstrates that macrophage
proliferation is a feature of the more aggressive forms of
human GN and that this local proliferation may be an
important mechanism for amplifying macrophage-medi-
ated renal injury. The degree of local macrophage prolif-
eration may be a useful diagnostic and prognostic indicator
for human GN. Furthermore, the mechanisms driving local
macrophage proliferation could provide new therapeutic
targets for the treatment of aggressive forms of GN.
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APPENDIX
Abbreviations used in this article are: APAAP, alkaline phosphatase
anti-alkaline phosphatase complexes; cres GN, crescent glomerulonephri-
tis; FCS, fetal calf serum; FGS, focal glomerulosclerosis; GBM, glomer-
ular basement membrane; gcs, glomerular cross section; GM-CSF, gran-
ulocyte-macrophage colony-stimulating factor; GN, glomerulonephritis;
IgAN, immunoglobulin A nephropathy; lupus II, lupus nephritis WHO
class II; lupus IV, lupus nephritis WHO class IV; mAb, monoclonal
antibodies; MCD, minimal change disease; MCPGN, mesangiocapillary
proliferative glomerulonephritis; M-CSF, macrophage colony-stimulating
factor; memb GN, membranous GN; MIF, macrophage migration inhib-
itory factor; non-IgA MPGN, non-IgA mesangial proliferative glomerulo-
nephritis; PAP, peroxidase anti-peroxidase complexes; PBS, phosphate
buffered saline; PCNA, proliferating cell nuclear antigen; vasc GN,
nephritis associated with vasculitis.
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